Glaucoma: The Silent Thief of Sight — How to Detect and Stop It Before Vision Is Lost

Of all the eye conditions I see in my OPD — patients from Meerut, Muzaffarnagar, Baghpat, Hapur, and the wider western Uttar Pradesh region — glaucoma is the one that concerns me most. Not because it is the most common, but because it is uniquely treacherous: it causes permanent, irreversible blindness, and in its most prevalent form, it does so without a single symptom until significant, life-altering damage has already occurred. Understanding glaucoma — what it is, who is at risk, and how it is detected and managed — could literally save your sight.

Why Glaucoma Is Called the "Silent Thief of Sight"

The name is earned. In Primary Open-Angle Glaucoma — the most common form — there is no pain, no redness, no visible change in the eye's appearance, and no noticeable loss of central vision in the early and middle stages. The damage begins at the peripheral edges of your visual field and creeps inward so gradually, over years, that the brain compensates without you realising it. By the time a patient notices a change in their central vision — blurring, tunnel vision — they may have already lost 40 to 50 percent of their optic nerve fibres. And those fibres do not regenerate. Ever.

In India, glaucoma is estimated to affect over 12 million people, making it the second leading cause of blindness after cataract — but unlike cataract, whose vision loss is fully reversible with surgery, the blindness caused by glaucoma is permanent. Nearly half of those affected in our country are undiagnosed, largely because the disease causes no discomfort in its early stages and routine eye pressure checks are not yet a widespread habit in our communities.

How Glaucoma Damages the Eye

Inside the eye, a clear fluid called aqueous humour is continuously produced by a structure called the ciliary body. This fluid nourishes the lens and cornea, then drains out through a microscopic sieve-like structure called the trabecular meshwork, located where the iris meets the cornea. This drainage system maintains a steady intraocular pressure (IOP), normally between 10 and 21 mmHg.

In glaucoma, this drainage becomes impaired — either because the trabecular meshwork becomes less efficient over time, or because the drainage angle closes off suddenly or gradually. Fluid builds up, IOP rises, and the elevated pressure is transmitted down the eye to the optic nerve at the back. The optic nerve — the cable that carries visual information from the retina to the brain — is gradually compressed and starved of blood supply. Its 1.2 million nerve fibres begin to die, systematically, from the periphery inward. Once gone, they cannot be replaced.

Types of Glaucoma

Glaucoma is not a single disease. Understanding which type you may have is essential for selecting the right treatment:

• Primary Open-Angle Glaucoma (POAG): The most common form in India and worldwide. The drainage angle between the iris and cornea appears open and normal on examination, but the trabecular meshwork functions poorly. IOP rises slowly and silently over years. There are no symptoms until advanced stages. This is the form most people mean when they say "glaucoma."
• Angle-Closure Glaucoma: The drainage angle is narrow or completely blocked by the iris, preventing aqueous outflow. This can occur suddenly — an acute angle-closure attack — causing severe eye pain, headache, nausea, blurred vision, and halos around lights. This is a medical emergency requiring immediate treatment. Angle-closure is significantly more common in South and East Asian populations, including Indians, than in Caucasian populations — a factor that makes screening in our community particularly important.
• Normal-Tension Glaucoma (NTG): A perplexing but important variant in which optic nerve damage occurs despite IOP consistently within the normal range. It is thought to involve a compromised blood supply to the optic nerve, and is associated with migraine, low blood pressure, and vascular disease. It requires the same vigilance and treatment as high-pressure glaucoma.
• Congenital and Developmental Glaucoma: Rare forms occurring in infants and young children, caused by abnormal development of the drainage angle. Warning signs include an unusually large, cloudy cornea, excessive tearing, and light sensitivity in a young child. These require prompt surgical intervention.

Who Is at Risk?

While glaucoma can affect anyone, certain factors significantly raise your risk. You should prioritise regular eye pressure screening if you have any of the following:

• Age above 40 years — the risk approximately doubles every decade after this age
• A parent, sibling, or child with glaucoma — having a first-degree relative with the condition increases your risk four to nine times
• High myopia (short-sightedness greater than -3 dioptres) — associated with structural vulnerability of the optic nerve
• Diabetes mellitus — increases risk of both open-angle glaucoma and retinal nerve fibre layer thinning
• Hypertension and cardiovascular disease — affect optic nerve blood supply
• Long-term use of steroid medications in any form — eye drops, nasal sprays, oral tablets, or skin creams — which can raise IOP even when used as prescribed
• Previous eye injury or surgery
• Thin central cornea (measured during a comprehensive eye exam)

How We Diagnose Glaucoma

Glaucoma diagnosis is not a single test — it requires a battery of assessments, because no one parameter tells the full story. At Haripriya Eye Care Centre, our glaucoma evaluation includes:

• Tonometry (IOP measurement): Using a non-contact tonometer or Goldmann applanation tonometry — the gold standard — to measure intraocular pressure. A single normal reading does not rule out glaucoma, and a single elevated reading does not confirm it; trends over time matter.
• Gonioscopy: A specialised contact lens examination that allows me to directly visualise the drainage angle. This is the only way to classify glaucoma as open-angle or angle-closure, which dictates treatment entirely.
• OCT of the optic nerve and retinal nerve fibre layer (RNFL): Optical coherence tomography provides a high-resolution cross-sectional image of the optic nerve head and surrounding nerve fibre layer. We can detect nerve fibre thinning — the structural hallmark of glaucoma — often before any visual field loss is measurable. This is one of the most powerful tools for early detection.
• Visual field testing (perimetry): A computerised test that maps your entire field of vision. Characteristic glaucomatous patterns — arcuate scotomas, nasal steps, altitudinal defects — confirm functional damage and help monitor progression over serial tests.
• Fundus examination: Dilated examination of the optic disc, assessing the cup-to-disc ratio (enlarged cupping is a key glaucoma sign), disc haemorrhages, and nerve fibre layer defects visible as wedge-shaped dark streaks.

Treatment: Stopping the Thief in Its Tracks

The goal of all glaucoma treatment is to lower intraocular pressure sufficiently to prevent further optic nerve damage. The vision already lost cannot be recovered — but with good adherence and regular monitoring, most patients preserve useful vision for life. Treatment follows a stepwise approach:

Step 1 — Eye Drops

For most patients, the first line of treatment is pressure-lowering eye drops. The main classes include:

• Prostaglandin analogues (latanoprost, bimatoprost, travoprost) — the most effective single agents, used once daily at night. They increase aqueous outflow through an alternate pathway.
• Beta-blockers (timolol) — reduce aqueous production. Used twice daily but require caution in patients with asthma, COPD, or bradycardia — a situation where our in-house cardiology team is invaluable for safe co-prescribing.
• Carbonic anhydrase inhibitors (dorzolamide, brinzolamide) — reduce aqueous production; available as drops or systemic tablets for acute situations.
• Alpha-2 agonists (brimonidine) — reduce production and increase alternate outflow.

Combinations of two or three classes are often used when a single agent is insufficient. Drop adherence — using them every day without fail — is the single biggest determinant of whether medical treatment succeeds.

Step 2 — Laser Treatment

• Selective Laser Trabeculoplasty (SLT): For open-angle glaucoma, SLT uses a gentle, targeted laser to stimulate the trabecular meshwork cells to drain more efficiently. It can lower IOP by 20 to 30 percent in responsive patients, often reducing the need for drops. It is painless, takes about 5 minutes, and can be repeated if needed.
• Laser Peripheral Iridotomy (LPI): The treatment of choice for angle-closure glaucoma. A tiny hole is made in the peripheral iris using a YAG laser, creating an alternative pathway for aqueous to reach the drainage angle. It is fast, highly effective, and also used preventively in narrow-angle patients before an acute attack occurs.

Step 3 — Surgery

When drops and laser are insufficient to halt progression, surgery is required. The most established procedure is trabeculectomy — creation of a new drainage channel from inside the eye to a reservoir (bleb) under the conjunctiva. Trabeculectomy, performed carefully with antimetabolite agents to prevent scarring, can achieve very low target pressures. For refractory cases, tube shunt surgery (Ahmed, Baerveldt implants) diverts aqueous to a plate implanted under the conjunctiva. Minimally invasive glaucoma surgeries (MIGS) are also increasingly available for mild-to-moderate disease, often combined with cataract surgery.

The Irreversible Reality — and the Power of Early Detection

I want every patient reading this to carry one fact: glaucoma cannot be cured, and the vision it takes cannot be returned. But it can be stopped. With early diagnosis — before significant nerve fibre loss — and consistent treatment, the overwhelming majority of glaucoma patients retain functional vision for their entire lives. A simple, painless tonometry test and optic disc examination, performed annually after the age of 40, is all it takes to catch most cases before they steal sight. If you live in Meerut, Ghaziabad, Muzaffarnagar, or anywhere in the western UP belt and have not had your eye pressure checked recently, please do not wait.